secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2026-10-02T13:25:23+00:00
Accession:  0001493152-26-045447
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.03, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Hepion raises authorized common stock to 750,000,000 shares via Delaware Certificate of Amendment
--------------------------------------------------------------------------------

- Certificate of Amendment filed with the Delaware Secretary of State and effective October 1, 2026, increased Hepion's authorized common stock to 750,000,000 shares.
- The filing does not state the prior authorized share count, the reason for the increase, or any planned issuance, financing or pricing terms tied to the new shares.
- Full text of the Certificate of Amendment is attached as Exhibit 3.1; the 8-K is signed by Interim CEO Gary Stetz and dated October 2, 2026.
- Hepion's common stock (HEPA) is quoted on the OTC QB; no change to par value of $0.0001 per share was disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226045447/0001493152-26-045447-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226045447/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-045447

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer